The University of Texas System

Lun Ma

Wei Chen

Disclosed herein are composite materials that comprise one or more nanophosphors capable of converting higher frequency, lower wavelength radiation into visible light. As used, the produced visible light enhances the amount of visible light already present from natural or artificial sources.

Nanophosphors for visible light enhancement

Disclosed is the use of copper cysteamine nanoparticles for use in photodynamic cancer therapy. The disclosed methods of treatment utilize microwave radiation as a means for activating the copper cysteamine photosensitizer.

Photodynamic therapy for use in treating cancer

Structure and luminescence properties of a new Cu-Cysteamine (Cu-Cy) crystal material are provided. The crystal structure of the Cu-Cy is determined by single crystal X-ray diffraction. It is found that the compound crystallizes in the monoclinic space group C2/c and cell parameters are a=7.5510(4) &#x212b;, b=16.9848(7) &#x212b;, c=7.8364(4) &#x212b;, &#x3b2;=104.798(3)&#xb0;. The new Cu-Cy crystal material of the invention is also useful for treatment of cancer.

Copper-cysteamine and methods of use

This invention relates to new phosphor materials exhibiting luminescence and methods for their production. More particularly, the invention relates to new europium-doped zinc sulfide-manganese (ZnS:Mn,Eu) phosphors and use thereof for radiation detection.

Europium-doped phosphor materials

Structure and luminescence properties of a new Cu-Cyteamine (Cu-Cy) crystal material are provided. The crystal structure of the Cu-Cy is determined by single crystal X-ray diffraction. It is found that the compound crystallizes in the monoclinic space group C2/c and cell parameters are a=7.5510(4) &#x212b;, b=16.9848(7) &#x212b;, c=7.8364(4) &#x212b;, &#x3b2;=104.798(3)&#xb0;. The new Cu-Cy crystal material of the invention is also useful for treatment of cancer.

Growing community of inventors

Arlington, TX, United States of America

Lun Ma